Human iPSC‐derived GABAergic interneuron transplantation restores circuit balance and cognitive function in an Alzheimer's disease model
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Xinzhe Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College (PUMC) & Chinese Academy of Medical Science(CAMS…. Hauptthemen laut MEDLINE: Alzheimer Disease, Induced Pluripotent Stem Cells, Interneurons, GABAergic Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program, Chinese Academy of Medical Sciences, Innovation Fund for Medical Sciences.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Alzheimer's disease (AD) is characterized by disrupted excitatory–inhibitory (E:I) balance and impaired synaptic function, yet current treatments fail to repair these fundamental circuit impairments. METHODS Human induced pluripotent stem cell‐derived post‐mitotic medial ganglionic eminence‐originated inhibitory neurons (MGE‐pINs) were bilaterally transplanted into the hippocampus of 10‐month‐old 5xFAD mice. Cell transplantation effects were assessed by behavioral analysis, electrophysiology, immunofluorescence staining, immunoblotting, and RNA sequencing analysis. RESULTS MGE‐pIN integration restored local inhibition, correcting E:I imbalance and suppressing electroencephalogram (EEG)‐detected epileptiform discharges. This network recovery, underpinned by normalized receptor subunit levels and restored synaptic plasticity – as evidenced by long‐term potentiation recordings, morphological analysis, and transcriptomic profiling – led to the rescue of cognitive deficits. Importantly, these functional benefits occurred independently of amyloid beta levels. DISCUSSION The study's findings suggest that targeted interneuron replacement can reverse network dysregulation and cognitive decline in AD, underscoring the potential of cell‐based modulation as a route to restore brain function in neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College (PUMC) & Chinese Academy of Medical Science(CAMS), Beijing, China.
- Mckusick-Zhang Center for Genetic Medicine, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, PUMC & CAMS, Beijing, China.
- State Key Laboratory of Complex, Severe, and Rare Diseases, PUMCH, Beijing, China.
ORCID-Profile: Qing Liu
Förderung
- National Key Research and Development Program
- Chinese Academy of Medical Sciences
- Innovation Fund for Medical Sciences
- PUMCH Talent Cultivation Program
- National Key Research and Development Program of China
Zitieren
APA
Zhang, X., Wang, G., Chen, H., Sun, Y., Wangliu, Z., Wang, L., Sun, M., Liu, Q., & Zhang, X. (2026). Human iPSC‐derived GABAergic interneuron transplantation restores circuit balance and cognitive function in an Alzheimer's disease model. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71378
Vancouver
Zhang X, Wang G, Chen H, Sun Y, Wangliu Z, Wang L, et al. Human iPSC‐derived GABAergic interneuron transplantation restores circuit balance and cognitive function in an Alzheimer's disease model. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71378
BibTeX
@article{Zhang2026,
author = {Zhang, Xinzhe and Wang, Gaojie and Chen, Haodong and Sun, Ye and Wangliu, Ziteng and Wang, Lijing and Sun, Miao and Liu, Qing and Zhang, Xue},
title = {Human iPSC‐derived GABAergic interneuron transplantation restores circuit balance and cognitive function in an Alzheimer's disease model},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71378}
}
EUVIMED